Pinnacle Wealth Planning Services, Inc. Biocryst Pharmaceuticals Inc Transaction History
Pinnacle Wealth Planning Services, Inc.
- $4.39 Billion
- Q4 2024
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 12,710 shares of BCRX stock, worth $111,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,710
Previous 24,744
48.63%
Holding current value
$111,593
Previous $188,000
49.47%
% of portfolio
0.0%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
284Shares Held
173MCall Options Held
612KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA21.9MShares$192 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$175 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$104 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$79.8 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$77.7 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.63B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...